Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.46 |
| ▸ | LPL | P06858 | 13/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | F11 | P03951 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29264048 | 1.00 | LIPG (0.46) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL28217 | 0.86 | LIPG (0.56) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL12304949 | 0.86 | LPL (0.42) | LIPGLPLF11 | |
| SCHEMBL31187675 | 0.86 | LPL (0.42) | LIPGLPLF11 | |
| SCHEMBL16483120 | 0.82 | LIPG (0.43) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL23753688 | 0.81 | LPL (0.55) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL30565011 | 0.81 | LPL (0.55) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL12451902 | 0.80 | LPL (0.54) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL24473145 | 0.79 | LPL (0.50) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL12200535 | 0.79 | LIPG (0.45) | LIPGLPLIRAK4EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240260467-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240260467-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME | NFE2L2, ELP1, ESR1 | LIPG 2650/4885LPL 2416/4885CYP1A2 528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.